29 growth-stage insurtech investors
We list 29 growth-stage insurtech investors as of November 2026: 16 have an SEC filing on file and 13 were checked on the firm's own website or an official register, and the list was last checked on 9 Nov 2026. The states with the most are New York (5), Illinois (2) and Florida (1).
Top 5 growth-stage insurtech investors, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
Motive Venture
Type: VC firm · HQ: New York, NY · Stages: Pre-seed, Seed, Series A, Growth · Focus: Insurtech, Fintech, AI, Data · Latest activity: New fund, Aug 2026 · Fund size on file: $200M (SEC Form D, 2025)
Latest fund filing dated Aug 2026; $200M fund on file (SEC Form D, 2025); states insurtech as a focus; backs pre-seed, seed, Series A; 8 named decision-makers on file.
Sandbox Clinical Ventures
Type: VC firm · HQ: Chicago, IL · Stages: Seed, Series A, Series B, Growth · Focus: Insurtech, Healthtech, AI, Fintech · Latest activity: New fund, Sep 2026 · Fund size on file: $100M (SEC Form D, 2021)
Latest fund filing dated Sep 2026; $100M fund on file (SEC Form D, 2021); states insurtech as a focus; backs seed, Series A, Series B; 8 named decision-makers on file.
Actyus
Type: Fund manager · HQ: Spain · Stages: Growth · Focus: Insurtech, Fintech, Proptech · Latest activity: New fund, Jul 2026 · Fund size or assets: €60M (own site)
Latest fund filing dated Jul 2026; €60M on file (own site); states insurtech as a focus; backs growth-stage; 1 named decision-maker on file.
Centana Growth Partners
Type: VC firm · HQ: New York, NY · Stages: Growth · Focus: Insurtech, Fintech, AI, Cybersecurity · Latest activity: New deal, Dec 2025 · Fund size on file: $600M (SEC Form D, 2024)
Dated new deal in Dec 2025; $600M fund on file (SEC Form D, 2024); states insurtech as a focus; backs growth-stage; 8 named decision-makers on file.
Nextalia SGR (Nextalia Ventures)
Type: Fund manager · HQ: Milan, Italy · Stages: Series A, Series B, Growth · Focus: Insurtech, B2B, SaaS, Fintech · Latest activity: New fund, Oct 2026
Latest fund filing dated Oct 2026; states insurtech as a focus; backs Series A, Series B, growth-stage; 4 named decision-makers on file.
First 14 of 29 growth-stage insurtech investors
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| Motive Venture | VC firm | New York, NY | Pre-seed, Seed, Series A, Growth | Insurtech, Fintech, AI, Data | New fund, Aug 2026 | $200M (SEC Form D, 2025) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Sandbox Clinical Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Insurtech, Healthtech, AI, Fintech | New fund, Sep 2026 | $100M (SEC Form D, 2021) | 4 Nov 2026 | 8 names, firm email · Unlock |
| Actyus | Fund manager | Spain | Growth | Insurtech, Fintech, Proptech | New fund, Jul 2026 | €60M (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| Centana Growth Partners | VC firm | New York, NY | Growth | Insurtech, Fintech, AI, Cybersecurity | New deal, Dec 2025 | $600M (SEC Form D, 2024) | 5 Nov 2026 | 8 names, firm email · Unlock |
| Nextalia SGR (Nextalia Ventures) | Fund manager | Milan, Italy | Series A, Series B, Growth | Insurtech, B2B, SaaS, Fintech | New fund, Oct 2026 | 9 Nov 2026 | 4 names, firm email · Unlock | |
| AVP | VC firm | London, United Kingdom | Series A, Series B, Growth, Late stage | Insurtech, Fintech, SaaS, Healthtech | Portfolio news, Oct 2026 | 4 Nov 2026 | 8 names · Unlock | |
| Mundi Ventures | VC firm | Madrid, Spain | Seed, Series A, Series B, Growth | Insurtech, Deep Tech, Climate Tech, Fintech | New deal, Oct 2026 | 7 Nov 2026 | 3 names · Unlock | |
| Committed Capital | SEIS/EIS fund | London, United Kingdom | Growth | Insurtech, Fintech, Cybersecurity, AI | Portfolio news, Apr 2025 | $150M (SEC Form D, 2025) | 4 Nov 2026 | 8 names, firm email · Unlock |
| NIYA Partners | VC firm | Miami, FL | Series A, Series B, Growth | Insurtech, Fintech, AI, Generalist | New fund, May 2026 | $11M (SEC Form D, 2026) | 4 Nov 2026 | LinkedIn page · Unlock |
| Oxford Capital | SEIS/EIS fund | Oxford, United Kingdom | Pre-seed, Seed, Series A, Growth | Insurtech, Fintech, Healthtech, AI | Portfolio news, Apr 2026 | £500M (own site) | 4 Nov 2026 | 8 names · Unlock |
| Moderne Ventures | VC firm | Chicago, IL | Seed, Series A, Series B, Growth | Insurtech, AI, Robotics, Deep Tech | New fund, Apr 2026 | $117M (SEC Form D, 2022) | 4 Nov 2026 | 8 names, firm email · Unlock |
| FJ Labs | VC firm | New York, NY | Pre-seed, Seed, Series A, Series B, Growth | Insurtech, AI, Fintech, Energy | New fund, Mar 2026 | $122M (SEC Form D, 2021) | 4 Nov 2026 | 8 names · Unlock |
| BlackFin Capital Partners | Fund manager | Paris, France | Growth | Insurtech, Fintech | €4.0B (own site) | 7 Nov 2026 | 4 names · Unlock | |
| Optimist Ventures | VC firm | New York, NY | Growth, Any stage | Insurtech, AI | New fund, Apr 2026 | $10M (SEC Form D, 2025) | 4 Nov 2026 | 1 name, firm email · Unlock |
You are seeing 14 of 29. The full list adds 15 more investors and 149 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 29 break down
By region
| Region | On this list | Share |
|---|---|---|
| United States | 15 | 52% |
| United Kingdom | 7 | 24% |
| Europe | 6 | 21% |
By US state
| US state | On this list | Share |
|---|---|---|
| New York | 5 | 17% |
| Illinois | 2 | 7% |
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 21 | 72% |
| Fund manager | 3 | 10% |
| SEIS/EIS fund | 3 | 10% |
| Corporate VC | 2 | 7% |
Method and limits
- Source
- 16 of the 29 rows carry an SEC filing (Form D or Form ADV). All 29 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states insurtech as a focus on its own site, or we observed it in the firm's portfolio. Stage: the firm states that it invests at growth-stage.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (35: full marks within 3 months, then stepping down at 6, 12 and 24 months), share of the observed portfolio in this sector (25; half of that when the sector is stated only), stage focus (15: all of it when growth-stage is the only stage the firm states, split evenly when it states more), size of the fund on file on a log scale (15) and completeness of the public record (10). Stage focus is our research, not an SEC figure. It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 29 rows: stage 29, sector 29, fund size 21, website 29. In the paid file: named decision-makers on 26 rows, firm email on 13, LinkedIn page on 19, check size on 9.
- Corrections
- Email hello@theinvestordatabase.com or use the update form. We act within 5 working days.
Questions
How many growth-stage insurtech investors are there?
We list 29 as of November 2026. 12 of the 29 have a fund filing or a dated deal in the last 12 months.
Which growth-stage insurtech investors raised a new fund in the last 12 months?
6 of the 29 have a fund filing dated in the last 12 months. The most recent on this list are Sandbox Clinical Ventures (Sep 2026), Motive Venture (Aug 2026) and NIYA Partners (May 2026).
What is the typical fund size of growth-stage insurtech investors?
The median fund size on file for this list is $122M, across the 11 firms with a size on an SEC Form D. The fund on file is each firm's main fund, which is not always its newest. The other 18 do not disclose a size there.
How do I contact growth-stage insurtech investors?
The paid file holds 149 named decision-makers across 26 of these 29 and a firm email for 13. We publish the address a firm lists itself, never a personal email. Each free row links to a profile with the firm's website.
Where does the data on growth-stage insurtech investors come from?
16 of the 29 rows have an SEC filing on file (Form D or Form ADV) and 13 were checked on the firm's own website or an official register. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Broader lists
Narrower lists
Related lists
Growth-stage SaaS investors (344)Growth-stage healthtech investors (316)Growth-stage AI investors (295)Growth-stage fintech investors (214)Growth-stage deep tech investors (191)Growth-stage climate tech investors (189)Growth-stage consumer investors (124)Growth-stage B2B investors (119)Growth-stage biotech investors (109)Growth-stage medtech investors (107)Growth-stage energy investors (102)Growth-stage cybersecurity investors (92)Growth-stage industrial tech investors (81)Growth-stage food and beverage investors (67)Seed insurtech investors (61)Growth-stage mobility investors (55)Growth-stage hardware investors (46)Growth-stage agritech investors (46)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to insurtech and growth-stage. Guide: how many investors to pitch. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.